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Abstract.  Mastoparan,  a basic tetradecapeptide iso- 
lated from wasp venom, is a novel mitogen for Swiss 
3T3 cells. This peptide induced DNA synthesis in syn- 
ergy with insulin in a concentration-dependent man- 
ner; half-maximum and maximum responses were 
achieved at  14 and  17 #M, respectively. Mastoparan 
also stimulated DNA synthesis in the presence of 
other growth promoting factors including  bombesin, 
insulin-like growth factor-I, and platelet-derived 
growth factor. The synergistic mitogenic stimulation 
by mastoparan  can be dissociated from activation of 
phospholipase C. Mastoparan did not stimulate phos- 
phoinositide breakdown, Ca  2+ mobilization or protein 
kinase C-mediated phosphorylation of a major cellular 
substrate or transmodulation  of the epidermal growth 
factor receptor.  In contrast,  mastoparan  stimulated ar- 
achidonic acid release, prostaglandin  Fa production, 
and enhanced cAMP accumulation in the presence of 
forskolin.  These responses were inhibited by prior 
treatment with pertussis toxin.  Hence, mastoparan 
stimulates arachidonic acid release via a pertussis 
toxin-sensitive G protein in Swiss 3T3 cells. Arachi- 
donic acid, like mastoparan,  stimulated DNA synthe- 
sis in the presence of insulin.  The ability of mastopa- 
ran to stimulate mitogenesis was reduced by pertussis 
toxin treatment.  These results demonstrate,  for the 
first time, that mastoparan stimulates reinitiation  of 
DNA synthesis in Swiss 3T3 cells and indicate that 
this peptide may be a useful probe to elucidate signal 
transduction mechanisms in mitogenesis. 
LUCIDATION of the molecular mechanisms  leading to 
cell proliferation requires the identification of  the sig- 
nal transduction pathways that,  when activated,  in- 
duce a mitogenic response.  In this  respect cultured fibro- 
blasts,  such as murine 3T3 cells,  have emerged as a model 
system.  These cells cease to proliferate when they deplete 
the medium of its growth promoting activity and enter a 
quiescent or nondividing  state.  However, such cells remain 
viable and can be stimulated to reinitiate  DNA synthesis and 
cell division either by replenishing the medium with fresh se- 
rum or by the addition of polypeptide growth factors,  neu- 
ropeptides and pharmacological  agents  in serum-free me- 
dium. Extensive analysis of early signaling events using this 
model has revealed the existence of multiple signal transduc- 
tion pathways that in synergy initiate a proliferative  response 
(Rozengurt,  1986). The discovery of additional mitogens can 
provide novel approaches to explore cellular signaling path- 
ways leading  to cell proliferation. 
Mastoparan,  an amphiphilic tetradecapeptide isolated from 
wasp venom, stimulates exocytosis in a variety of target cells 
J.  Girs present address is Unitat de Bioquirnica, Facultat d'Odontologia, 
Universitat de Barcelona, 08907  Hospitalet de Llobregat, Spain. 
including  mast (Hirai et al.,  1979),  chromaflin  (Kuroda  et 
al., 1980), pituitary (Carnoratto  and Gradison, 1985; Kuri- 
hara et al.,  1986), and pancreatic  (Yokokawa et al.,  1989) 
cells.  The early events in the action of mastoparan include 
the breakdown of phosphoinositides and the mobilization  of 
Ca  2+ from internal  stores (Okano et al.,  1985; Perianin  and 
Snyderman,  1989; Tohkin et al., 1990). The mechanism by 
which mastoparan activates  these signaling  pathways does 
not involve specific membrane receptors (Aridor et al., 1990). 
Instead, mastoparan acts directly on G proteins reconstituted 
into phospholipid  vesicles to stimulate  guanine  nucleotide 
exchange and GTP hydrolysis by a mechanism similar to that 
used by surface receptors (Higashijima  et al.,  1988, 1990; 
Mousli et al., 1990; Weingarten et al., 1990). This receptor- 
like activity of mastoparan could provide a novel probe to 
activate G proteins in intact cells. Indeed, some of the cellu- 
lar and molecular effects of mastoparan can be blocked by 
pertussis toxin (Aridor et al., 1990; Higashijima et al., 1987; 
Mousli et al.,  1989;  Saito et al.,  1987; Yokokawa et al., 
1989), which ADP ribosylates and functionally inactivates 
a family of G proteins including transducin,  Gi, and Go (Gil- 
man,  1987).  In addition,  mastoparan has been previously 
shown  to interact  with phospholipids (Higashijima  et al. 
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activity leading  to the generation  of arachidonic  acid (Ar- 
giolas and Pisano,  1983). Some of the early signals elicited 
by mastoparan in secretory cells, e.g., phosphoinositide break- 
down, Ca  2+ mobilization,  and arachidonic acid release, have 
also been implicated in triggering cell proliferation  by mito- 
genic neuropeptides and polypeptide growth factors in quies- 
cent cells (Rozengurt, 1986). As yet, however, it is not known 
which signal transduction  pathways are activated by masto- 
paran in quiescent cells nor whether this peptide can act as 
a mitogen  for these cells. 
In the present study we report that mastoparan, at micro- 
molar concentrations,  stimulates reinitiation of DNA synthe- 
sis in Swiss 3T3 cells acting synergistically  with insulin and 
other growth promoting  factors.  Before the stimulation  of 
DNA synthesis, mastoparan increases pertussis toxin-sensi- 
tive arachidonic  acid release in the absence of inositol phos- 
phate accumulation. Thus, mastoparan provides a novel probe 
to elucidate signal transduction pathways in the mitogenic re- 
sponse. 
Materials and Methods 
Cell Culture 
Stock cultures of Swiss 3T3 cells were propagated as described previously 
(Rozengurt and  Sinnett-Smith,  1983).  For experimental purposes, cells 
were subcultured in 33- or 90-ram Nunc dishes with Dulbecco's modified 
Eagles medium (DMEM) supplemented with 10%  fetal bovine serum and 
incubated in a humidified atmosphere of 10% CO2, 90% air at 37°C until 
they became confluent and quiescent (6-8 d). 
pH]Thymidine Incorporation Assay 
Determinations of DNA synthesis were performed as previously described 
(Dicker and Rozengurt,  1980).  Briefly,  cultures were washed twice with 
DMEM and incubated in DMEM/Waymouth's medium (l:l[vol/vol]) con- 
raining [3H]thymidine (1/~Ci/ml; 1/~M) and various additions as described 
in the experiments. After 40 h, the cultures were washed twice with PBS 
and incubated in 5 % trichloracetic acid for 30 rain at 4°C. Trichloracetic 
acid was then removed and the cultures washed twice with ethanol and ex- 
tracted in 1 ml of 2% Na2CO3, 0.1 M NaOH,  1% SDS. Incorporation was 
determined by scintillation counting in 10 ml of picofluor. 
Autoradiography of  Labeled Nuclei 
Labeled nuclei were determined by autoradiography as described previ- 
ously (Dicker and Rozengurt,  1980).  Briefly,  cultures were washed twice 
with  DMEM  and  incubated  in  2  ml  of DMEM/Waymouth's  medium 
(l:l[vol/vol]) containing [3H]thymidine  (5 t~Ci/ml)  and the indicated fac- 
tors. After 40 h the medium was removed and the cultures were fixed in 
formol/saline (l:9[vol/vol]).  The cultures were washed twice with Tris- 
saline, pH 7.4 at 4"C, fixed twice (for 5 and 2 min) with 5% trichloracetic 
acid at 4°C, and washed three times with 70% ethanol. Autoradiographic 
film was put on the cultures and developed after a  1-wk exposure. After 
staining with Giemsa, the labeled nuclei were counted. 
Determination of Total Inositol Phosphates 
Confluent and quiescent cells grown on 90-ram dishes were labeled with 
5 pCi/ml of v-myo-[3H]inositol for 24 h at 37°C in conditioned medium. 
The cells were washed twice with DMEM preincubated for 20  rain in 
DMEM and then for 10 rain in DMEM containing 20 mM LiC1. Mastopao 
ran or bombesin were then added and the cells incubated for the indicated 
time. The incubations were stopped by rapidly replacing the medium with 
ice-cold 3% perchloric acid. After 30 min at 40C, the acid soluble extracts 
1. Abbreviations used in this paper:  IGF-I, insulin-like growth factor  1; 
PDBu, phorbol  12,13-dihutyrate;  PGE2,  prostaglandin E2;  PLA2, phos- 
pholipase A2. 
were collected and neutralized (pH 7-8) with 2 M K2CO3, containing 10 
mM EDTA and 100 mM Hepes. Samples were analyzed for their content 
of  total inositol phosphates by anion exchange chromatography using a Bio- 
Rad AG1X8 resin (Bio-Rad Laboratories, Richmond, CA) and elution with 
I  M ammonium formate/0.1 M  formic acid was performed as previously 
described (Berridge et al.,  1983;  Ntnberg and Rozangurt,  1988). 
80 K Phosphorylation 
Confluent and quiescent cells grown on 35-ram dishes were washed twice 
in phosphate-free  DMEM and incubated for 5 h in 1 ml of  the same medium 
containing 200 pCi 32p 1  . Pepddes were then added for various times. The 
reaction was stopped by removing the medium and rapidly washing the cul- 
ture twice with TBS. The cells were immediately extracted with 100/~1 of 
a solution containing 100 mM Tris-HCl, pH 6.9, 0.5% Triton X-100, 2 mM 
EGTA,  10 mM sodium fluoride, 50/~M PMSF, 3.5/zg/ml aprotmin for 
5 min at room temperature. The extract was heated at 100°C for 5 rain, cen- 
trifnged, and the supernatant was then mixed with an equal volume of 2× 
SDS  sample buffer.  One-dimensional SDS-PAGE was  performed using 
7.5%  (wt/vol) acrylamide and 0.1% (wt/vol) SDS (Laemmli,  1970). 
'~Ca  ~ E~ux 
Quiescent cultures of Swiss 31"3 cells were equilibrated with 45Ca2+ by in- 
cubating them for 14-16  h  in conditioned medium containing 5  ~,Ci/rrd 
45Ca  2+. Mastoparan or bombesin were added to the cultures and after 30 
rain of incubation at 37°C the extracellniar medium was removed and the 
cells rapidly washed seven times with DMEM containing 3 mM EGTA. 
Cellular 45Ca2+ was extracted with 0.1 N NaOH, 2% Na2CO3,  1% SDS, 
and determined by scintillation counting. 
~z~I-EGF Binding Assay 
Quiescent 3T3 cells were washed twice with DMEM at 37°C and incubated 
in a mixture of 1:1  DMEM and Waymouth's  medium containing 50 mM 
Hepes, pH 7.0 at 37°C and factors as indicated. After 1 h, cells were then 
incubated at 4°C in PBS (pH 7.2) containing 25 mM Hepes and 0.5 ng/ml 
(110,000  cpm/ng)  125I-EGE  After 2  h,  cells were washed rapidly with 
PBS, extracted with 0.1  M  NaOH containing 2% Na2CO3 and 1% SDS, 
and  cell-associated radioactivity was  determined in  a  gamma  counter. 
Nonspecific binding was determined as cell-associated radioactivity in the 
presence of a 250-fold excess of unlabeled EGF as previously described 
(Zachary et ai.,  1986). 
Arachidonic Acid Release 
Confluent and quiescent cells in 33-ram dishes were labeled for 14-16  h 
with  1 tzCi/rni  [3H]arachidonic acid in  conditioned medium.  The cells 
were then washed 3 times with DMEM and incubated at 370C  for 30 rain 
in 1 ml DMEM/Waymouth (1:1) containing mastoparan or bombesin as in- 
dicated. The medium was collected and centrifuged for 5 rain at 2,000 g 
to remove contaminating cellular debris and the level of radioactivity mea- 
sured by scintillation counting. 
Measurement of  Prostaglandin E2 (PGE2) Release 
Cultures were washed twice with DMEM and incubated at 37°C for 1 h 
in the required conditions. After this time the medium was removed and 
stored at 4°C. All vessels used were made of polypropylene or siliconised 
glassware. Measurements of prostaglandin E2 (PGE2)  were performed by 
radioimmunoassay using a  125I-PGE2 assay system. Aliquots of samples 
were diluted in assay buffer containing 0.9% NaC1,  0.01 M EDTA, 0.3% 
bovine 7-globulin, 0.005%  Triton Xol00,  0.05%  sodium azide, 25  mM 
phosphate buffer, pH 6.8. The samples were then bound to a rabbit anti- 
PGE2 antibody using ~25I-PGE2 as a competitive tracer for 16 h at 4°C. Af- 
ter this time the immune complexes were precipitated by the addition of 
16%  polyethylene glycol, 0.05%  sodium azide,  and 50  m_M phosphate 
buffer,  pH 6.8 for 30 rain at 4°C. Samples were centrifuged for 30 win at 
2,000 g and the supernatants removed. The resulting pellets were counted 
in a gamma counter (Beckman Instruments Inc., Palo Alto, CA). Additions 
of growth factors to the medium had no effect on the radioimmunoassay. 
Measurement of  cAMP 
Confluent and quiescent cells grown in 33-ram dishes were washed three 
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in the presence of various factors.  The medium was then rapidly replaced 
with 200 pl of 0.1 M HC1 and incubated for 20 min at 4°C.  The solution 
was then diluted into 50 mM sodium acetate buffer, pH 5.8 and cAMP levels 
were determined using a commercial radioimmunoassay  kit. The precipi- 
tated protein, remaining on the dish, was dissolved in 1 mi of 2% Na2CO3, 
0.1 M NaOH,  and measured using the bicinchoninic acid reagent. 
Materials 
Mastoparan and pertussis toxin were obtained from Peninsula Laborato- 
ties, Inc.  (Belmont, CA).  Bombesin, EGF,  bovine insulin, and phorbol- 
12,13-dibutyrate  (PDBu) were from Sigma Chemical Co. (St. Louis, MO). 
Fetal bovine serum was  from Gibco Laboratories (Grand Island, NY). 
C-sis recombinant PDGF, recombinant insulin-like growth factor 1 (IGF-1), 
~z~I-EGF, [3I-I]thymidine,  [32p]Pi (carrier free), DR-myo [3H]inositol, ~CaCI, 
[5, 6, 8, 9, 11, 12, 14, 15-3H]arachidonic acid, and cAMP radioimmunoas- 
say kit were purchased from Amersham International (Amersham, UK). 
125I-PGE2 radioimmunoassay  system was from New England Nuclear (Bos- 
ton, MA). Bicinchoninic acid reagent was from Pierce Chemical Co. (Rock- 
ford, IL). Forskolin was from Calbiochem-Behting  Corp. (San Diego, CA). 
Dowex AG1-X8 (formate form) was obtained from Bio-Rad  Laboratories, 
Richmond, CA). All other materials were of the purest grade commercially 
available. 
Results 
Mastoparan Induced DNA Synthesis in Synergy 
with Other Mitogens 
Initial experiments revealed that addition of 10-20/~M mas- 
toparan  to  quiescent  cultures  of Swiss  3T3  cells  induced 
marked morphological changes and cytotoxic effects at the 
higher concentrations  (25-30 #tM).  To determine whether 
mastoparan can act as a mitogen for these cells,  confluent 
and quiescent cultures were incubated in medium containing 
insulin and increasing concentrations of mastoparan. Cumu- 
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Figure 1. (Left) Dose response for the stimulation of DNA synthesis 
by mastoparan. Confluent and quiescent cultures of Swiss 3T3 cells 
were washed and incubated  at 37°C in 2 ml DMEM/Waymouth 
medium containing  1 #Ci/ml [3H]thymidine and various concen- 
trations of mastoparan, in the absence (open circles) or in the pres- 
ence (closed circles) of insulin at 1 #g/ml. After 40 h DNA synthe- 
sis  was  assessed  by measuring  the  [~H]thymidine incorporated 
into acid precipitable material.  Each point is the mean +  SEM of 
eight determinations from four independent experiments expressed 
as a percentage of the incorporation induced by 10% FBS (4.5-6 x 
10  ~ cpm).  (Right) Effect of mastoparan on DNA  synthesis  as- 
sessed by autoradiography.  Cells were incubated at 37"C in 2 ml 
DMEM/Waymouth  medium containing  5 #Ci/ml  [3H]thymidine 
and various concentrations of mastoparan in the presence of insulin 
at 1 #g/ml.  10% fetal bovine serum produced 95% labeled nuclei. 
The values are the mean + SEM of 10 different microscopic fields 
from 2 different dishes. 
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Figure 2. Stimulation of DNA synthesis by mastoparan in the pres- 
ence of various growth factors. (Left) Dose-response curve for the 
stimulation of DNA synthesis by bombesin in the absence (open 
circles) or in the presence (closed circles) of 15/xM mastoparan. 
Each value is the mean of two determinations from one representa- 
tive experiment.  (Right) Effect of mastoparan on IGF-1, PDGE 
PDBu,  and  EGF stimulation  of DNA synthesis.  Cells  were in- 
cubated with different factors either in the absence (open bars) or 
in the presence (closed bars) of 15/~M mastoparan.  The concentra- 
tions of IGF-1, PDGF, PDBu,  and EGF were 20,  10,  100, and 10 
ng/ml, respectively. Each value is the mean of two determinations 
from one representative experiment. Similar results were obtained 
in two other independent experiments. 
lative [3H]thymidine incorporation was measured after 40 h 
of incubation. Fig.  1 (left),  shows that mastoparan caused a 
striking stimulation of DNA synthesis, in a narrow concen- 
tration range. Half of the maximum response was obtained 
at a concentration of 14 #M and the maximum effect was 
achieved at 17 #M.  Mastoparan added without insulin did 
not induce any significant  [3H]thymidine incorporation  in 
Swiss 3T3 cells (Fig.  1,  left). 
To assess whether mastoparan and insulin interact syner- 
gistically in eliciting  initiation  of DNA replication rather 
than in changing the specific activity of the [3H]thymidine 
precursor pool, quiescent cultures of Swiss 3T3 cells were 
treated  with  various  concentrations  of mastoparan  in  the 
presence of insulin and incorporation of pH]thymidine into 
DNA was quantified by autoradiography of labeled nuclei. 
As shown in Fig. 1 (right), mastoparan caused a marked en- 
hancement  of the  labeling  index  (from  10%  in  cultures 
treated with insulin alone to 78 % in cultures treated with in- 
sulin and 17 #M mastoparan). Thus, mastoparan and insulin 
synergistically enhance the proportion of cells that enter into 
DNA synthesis. 
Mastoparan also stimulated DNA synthesis in the pres- 
ence of other growth promoting factors including bombesin 
(Fig. 2, left),  IGF-1, PDGF, PDBu, or EGF (Fig. 2, right). 
The results shown in Figs. 1 and 2 demonstrate that mastopa- 
ran promotes synergistic stimulation of DNA synthesis. 
Mastoparan Does Not Stimulate Phosphoinositide 
Breakdown, Ca  t÷ Mobilization, or Protein Kinase C 
The mitogenic neuropeptides bombesin (Rozengurt and Sin- 
nett-Smith,  1983) and vasopressin (Rozengurt et al.,  1979) 
bind to distinct receptors on 3T3 cells and induce rapid pro- 
duction of inositol phosphates (Heslop et al., 1986; Lopez- 
Rivas et al.,  1987;  N~nherg  and  Rozengurt,  1988),  Ca  2+ 
mobilization leading to a decrease in cellular Ca  2÷ content 
and sustained activation of protein kinase C (Zachary et al., 
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not  stimulate  phospholipase 
C. (Left) Mastoparan does not 
increase the formation of ino- 
sitol phosphates in Swiss 3T3 
cells.  Quiescent  cells  grown 
on 90-mm dishes were loaded 
with 1 t~Ci/ml myo-[3H]inosi  - 
tol  and  preincubated  for 20 
min  with  20  mM  LiCI  in 
DMEM,  and  then  incubated 
for 10 min with different con- 
centrations  of mastoparan  or 
6  nM  bombesin  (B,  cross- 
hatched bars).  The acid-sol- 
uble inositol phosphates were 
determined  as  described  in 
Materials  and  Methods.  The 
results correspond to one rep- 
resentative experiment.  Simi- 
lax results  were obtained  in two other independent  experiments.  (Inset) Mastopaxan does not stimulate the phosphorylation  of the Mr 
80,000 protein kinase C substrate (80 K). Quiescent cells labeled with 32pi were treated with mastopaxan (+ insulin) or 6 nM bombesin 
(B) for 10 min. The incubation was terminated and the samples analyzed by SDS-PAGE as described  in Materials and Methods. (Right) 
Mastoparan  has no effect on 4SCa2+ efflux from quiescent cultures of 3T3 cells.  Quiescent 3T3 cells, preincubated  with 45Ca2+ were in- 
cubated with different concentrations  of mastopaxan (closed bars) or 6 nM bombesin (cross-hatched bar) for 10 min in the presence of 
the isotope. The radioactive medium was aspirated and the cultures were rapidly washed seven times with 2 ml of 3 mM EGTA-containing 
DMEM at 37°C. The radioactivity left in the cells was extracted and measured as described in Materials and Methods. The values represent 
the mean +  SEM of four to five determinations  from two independent experiments. 
1986; Rodriguez-Pena and Rozengurt,  1986) via a G protein- 
linked transduction pathway (Erusalimsky et al.,  1988; Erusa- 
limsky and Rozengurt, 1989; SinneR-Smith et al., 1990; Coffer 
et al.,  1990).  Mastoparan is known to stimulate Ins(1,4,5)P3 
synthesis and Ca  2+ mobilization in certain target cells (Ok- 
ano  et  al.,  1985;  Perianin  and  Snyderman,  1989;  Tohkin 
et al.,  1990),  presumably through direct activation of a  G 
protein coupled to phospholipase C. Hence, we determined 
whether mastoparan-induced mitogenesis was mediated by 
a  similar signaling pathway. Fig.  3  shows that mastoparan, 
at concentrations that induced mitogenesis, neither increased 
inositol phosphate production nor caused Ca  2+ mobilization 
from intracellular stores, as measured in *sCa2+-labeled cells. 
Similar results were obtained when the cells were incubated 
with  17  #M  mastoparan for 0.5,  1,  2,  or 4  h  (results  not 
shown). 
We next examined whether mastoparan treatment increases 
the phosphorylation of the 80 K protein, a major substrate 
Table L Effect of Various Concentrations of  Mastoparan 
on the Binding of mI-EGF 
EGF binding 
Addition  (percent of control) 
None  100 
Bombesin (6 nM)  19 +  2 
Mastoparan (15 #M)  102  +  7 
Mastoparan (17 tzM)  98 +  8 
Mastoparan (20 tiM)  94 +  14 
Quiescent Swiss 3T3 cells were incubated for 1 h at 37°C in binding medium 
containing bombesin (6 nM) or various concentrations of mastoparan.  After 
this time, the binding of nSI-EGF to intact cells was measured as described in 
Materials and Methods. The results are expressed as percentage of the control 
and correspond to the mean 5:  SEM of six independent experiments. 
of protein  kinase C  in  3T3  cells  (Rozengurt et al.,  1983; 
Rodriguez-Pena and Rozengurt,  1986a;  Erusalimsky et al., 
1988).  Mastoparan added for 10 min either in the absence 
or presence of insulin failed to increase 80 K phosphoryla- 
tion (Fig.  3, inset).  Similar results were obtained when the 
cells were incubated with mastoparan at 17 #M for 30 min 
(results not shown). Activation of protein kinase C is known 
to reduce the affinity of the EGF receptor for its ligand (Zach- 
ary et al.,  1986). Table I shows that mastoparan, at concen- 
trations up to 20 #M, did not alter 125I-EGF  binding to Swiss 
3T3 cells.  In contrast,  under identical experimental condi- 
tions, bombesin stimulated inositol phosphate accumulation, 
decreased Ca  2+ content, promoted 80 K phosphorylation, and 
Table II. Protein Kinase C Downregulafion Does Not 
Affect Mastoparan-induced DNA Synthesis 
PDBu 
Additions  pretreatment  DNA synthesis 
% 
Insulin  -  6  +  1 
+  8+1 
Insulin  +  mastoparan  -  55  +  9 
+  61+5 
Insulin  +  PDBu  -  93  +  2 
+  12+1 
Quiescent cells were incubated for 40 h in their own conditioned medium, in 
the absence or presence of PDBu (400 ng/ml). At this time, cells were washed 
with  DMEM  and  incubated  as  described  in  Materials  and  Methods  for 
[3H]thymidine incorporation in the presence of 1 #g/ml insulin and either 17 
p.M mastoparan or 100 ng/ml PDBu. Results are expressed as a percentage of 
the incorporation induced by  10%  fetal bovine serum and correspond to the 
means ±  SEM of three independent experiments with incubations in duplicate. 
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Figure 4. Effect of  mastoparan 
on arachidonic  acid release, 
PGEz production, and cAMP 
accumulation in control  and 
pertussis  toxin-treated  cells. 
(A) Arachidonic acid release. 
Quiescent cells were labeled 
for 16 h with 1/zCi/ml [~H]ar- 
achidonic acid preincubated in 
DMEM/Waymouth  medium 
either  in  the  absence  (open 
bars) or presence (closed  bars) 
of 100 ng/ml pertussis toxin 
for 3 h. At this time the cells 
were incubated with fresh me- 
dium  containing mastoparan 
at the indicated concentrations 
for 30 min. After this time the 
medium was removed and cen- 
trifuged for 5 min at 2,000 g 
to remove contaminating cel- 
lular debris and the superna- 
tant  was counted directly to 
monitor  arachidonic acid re- 
lease. (B) PGE2 release. Qui- 
escent ceils were preincubated 
in  DMEM/Waymouth either 
in the absence (open bars) or 
presence of 100 ng/ml pertussis toxin (closed  bars) for 3 h. At this 
time the cells were incubated with fresh medium containing mas- 
toparan at the indicated concentrations for 1 h. After this time the 
medium was removed and stored at 4°C and PGF_~ was measured 
as described in Materials and Methods. (C) cAMP accumulation. 
Cultures were preincubated in DMEM/Waymouth medium con- 
taining either 100 ng/ml pertussis toxin (closed  bars) or no addition 
(open bars) for 3 h. At this time the cells were incubated with fresh 
medium containing various concentrations of mastoparan in the 
presence of  25 #M forskolin. After 1 h the cellular content of  cAMP 
was measured. The values correspond to the mean + SEM of  three 
determinations from one representative experiment. 
inhibited ~SI-EGF binding in parallel cultures (Fig. 3; Ta- 
ble I). Furthermore, down regulation of protein kinase C by 
prolonged exposure to PDBu (Rodriguez-Pena and Rozen- 
gurt, 1984) did not prevent the mitogenic effect of mastopa- 
ran in the presence of insulin (Table U). Collectively, these 
results indicate that the mitogenic activity of mastoparan can 
be dissociated from activation of phospholipase C. 
Mastoparan Stimulates Arachidonic Acid Release 
It is known that mastoparan stimulates PLA2 activity from 
a variety of sources presumably by rendering the substrate 
more susceptible to PLA2 action (Argiolas  and Pisano,  1983). 
We therefore examined the effect of mastoparan on arachi- 
donic acid release in 3"1"3 cells. 
Fig. 4 A shows that rnastoparan induces a dose-dependent 
release of radioactivity into the medium from quiescent cul- 
tures prelabeled with  [3H]arachidonic acid.  Since arachi- 
donic acid is a major precursor for the synthesis of E-type 
prostaglandins, we examined the effect  of mastoparan on the 
production of PGF,2. As  shown  in  Fig.  4  B,  mastoparan 
caused a marked and dose-dependent release of PGFa from 
quiescent cultures of Swiss 3T3 cells. 
In  previous  studies,  bombesin  (Millar  and  Rozengurt, 
1988) and PDGF (Rozengurt et al., 1983b) have been shown 
to enhance cAMP accumulation via a  cyclooxygenase-de- 
pendent pathway. Although mastoparan did not increase the 
basal level of cellular cAMP, mastoparan enhanced cAMP 
accumulation in the presence of either the phosphodiesterase 
inhibitor IBMX (Table HI) or the diterpene forskolin, a direct 
activator of adenylate cyclase (Fig. 4  C).  The cyclooxyge- 
nase inhibitor indomethacin blocked mastoparan-stimulated 
production of PGFa (Table IV) and inhibited the enhance- 
ment of cAMP accumulation by the peptide in the presence 
of forskolin (results not shown). 
Pertussis toxin is known to ADP-ribosylate G  proteins 
thereby blocking their function in receptor-mediated signal 
transduction (Ui,  1990).  A  salient feature shown in Fig. 4 
is that arachidonic acid release, PGF_,2 output, and enhance- 
ment of cAMP accumulation induced by mastoparan were 
inhibited markedly by prior treatment (3 h) with 100 ng/ml 
pertussis toxin. These findings strongly suggest that masto- 
paran increases arachidonic acid release via a pertussis toxin- 
sensitive G protein. 
Arachidonic Acid Release as a Mitogenic Signal in 
Mastoparan Action 
Stimulation of a proliferative response in 3T3 cells requires 
the synergistic interaction of  multiple distinct signaling path- 
ways (Rozengurt, 1986). The preceding results raise the pos- 
sibility that stimulation of arachidonic acid release by mas- 
toparan may constitute a synergistic mitogenic signal. This 
possibility predicts that:  (a) externally applied arachidonic 
Table IlL Effect of  Mastoparan on cAMP Accumulation 
in the Presence of  lBMX 
Addition  cAMP 
(pmol/mg protein) 
None  3.6  4-  0.3 
Mastoparan  4.3  4-  0.1 
IBMX  5.1  4-  0.6 
Mastoparan  +  IBMX  12.7  4-  1.1 
Quiescent Swiss 3T3 cells were incubated for 1 h at 370C in DMEM containing 
mastoparan  (17 t~M), 50 I~M IBMX, or both.  After this time the cellular con- 
tent of cAMP  was measured as described in  Materials and  Methods.  The 
cAMP content  of cultures incubated for 4 h (instead of 1 h) without or with 
mastoparan was  4.9  5- 0.3  and  5.4  5- 0.5,  respectively. The  results cor- 
respond  to the mean +  SEM of three determinations. 
Table IV. Effect of  lndomethacin on Mastoparan-induced 
PGE2 Release 
Indomethacin 
Addition  (1  #M)  PGEa 
ng/ral 
None  -  1.6  4-  0.3 
Mastoparan  -  22.0  +  2.0 
None  +  1.3  4-  0.1 
Mastoparan  +  2.6  +  0.2 
Quiescent Swiss 3T3  cells were incubated  for  1 h  at 37"C  in DMEM  or 
DMEM plus 20 #M mastoparan  in the absence  (-) or presence (+) of I #M 
indomethacin.  After this time,  PGE2 release was measured as described in 
Materials and Methods.  The values correspond to the mean +  SEM  of three 
determinations. 
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Figure 5. (A) Dose response for the stimulation of DNA synthesis 
by arachidonic acid. Confluent and quiescent cultures of  these cells 
were exposed to 2 ml of DMEM/Waymouth medium containing 
0.1% fatty acid-free BSA.  1 ftCi/ml [3H]thymidine, and various 
concentrations of arachidonic acid, either in the absence (open cir- 
cles) or in the presence of 1 #g/ml insulin (closed circles).  (B) 
Effect of  pertussis toxin pretreatment on mastoparan stimulation of 
DNA synthesis. Cultures were preincubated in DMEM/Waymouth 
medium either in the absence (open circles) or in the presence of 
100 ng/ml pertussis toxin (closed circles) for 3 h. At this time me- 
dium was removed and the incubation continued in DMEM/Way- 
mouth medium containing 1 #Ci/ml [3H]thymidine, 1 #g/ml insu- 
lin, and different concentrations of mastoparan either in the ab- 
sence (open circles) or in the presence (closed circles) of 100 ng/ml 
pertussis toxin. After 40 h DNA synthesis was assessed by measur- 
ing the incorporation of pH]thymidine into precipitable material 
as described in Materials and Methods. The results represent the 
mean of two different dishes of one representative experiment ex- 
pressed as a percentage of the incorporation induced by 10% FBS. 
acid, like mastoparan, will act synergistically with insulin to 
induce mitogenesis in 3T3 ceils; (b) pertussis toxin treatment 
should reduce the mitogenlc response induced by mastopa- 
ran; and (c) agents that induce cAMP accumulation in the 
presence of mastoparan, such as IBMX or forskolin, should 
potentiate DNA synthesis induced by mastoparan and insu- 
lin.  The experiments presented in Figs.  5 and 6  were de- 
signed to test the predictions. 
100 
80 
o~  so 
._~  40 
20  g 
IO0 
~-  601 
t/I  I  [  [  4oj  
2O 
#/I 
0  5  10  15 
L 
20 
Mastoparan  (pM) 
Figure 6. Effect of  forskolin or 
IBMX on mastoparan stimu- 
lation  of DNA  synthesis in 
Swiss  3T3  ceils.  Confluent 
and quiescent cultures of  these 
cells were exposed to 2 ml of 
DMEM/Waymonth  medium 
containing 1 #Ci/ml  [3H]thy- 
midine,  1 #g/ml insulin, and 
various concentrations of mas- 
toparan either in the absence 
(open circles)  or presence of 
forskolin at 5 #M (closed cir- 
cles, top) or IBMX at 50 #M 
(closed circles, bottom). After 
40 h DNA synthesis was as- 
sessed by measuring the level 
of [3H]thymidine  incorporated 
into  acid  precipitable  mate- 
rial. Each point is the mean of 
two determinations from one 
representative experiment ex- 
pressed  as  a  percentage  of 
the incorporation induced by 
10% FBS. 
Cultures of Swiss 3T3 cells were exposed to various con- 
centrations of arachidonic acid in the absence or presence of 
insulin and assayed for [3I-I]thymidine incorporation as an 
indicator of DNA synthesis. Arachidonic acid potently syn- 
ergized with insulin to stimulate DNA synthesis (Fig. 5 A). 
As reported recently (Millar and Rozengurt, 1990), arachi- 
donic acid did not induce DNA synthesis in the absence of 
other  factors.  Furthermore,  the  ability of mastoparan  to 
stimulate  [3H]thymidine incorporation in  the  presence of 
insulin was markedly reduced by pertussis toxin treatment, 
especially at lower concentrations of peptide (Fig. 5 B). 
Mastoparan stimulates PGF~ release and, in the presence 
of forskolin or a phosphodiesterase inhibitor, elevates cAMP 
levels which is known as a mitogenic signal for Swiss 3T3 
cells (Rozengurt et al.,  1981,  1983; Rozengurt, 1986). Fig. 
6 shows that addition of either forskolin or IBMX strikingly 
potentiated the induction of DNA synthesis by various con- 
centrations of mastoparan in the presence of insulin. These 
potentiating effects were markedly reduced by prior treat- 
ment with pertussis toxin (results not shown). 
Discussion 
The present results demonstrate that mastoparan is a novel 
mitogen for Swiss  3T3 cells.  The peptide,  at micromolar 
concentrations,  stimulates  reinitiation  of DNA  synthesis 
only in synergistic combinations,  particularly with insulin 
and IGF-1.  Furthermore, mastoparan potentiates the mito- 
genic response elicited by bombesin or PDGF. Since its iso- 
lation from wasp venom as a mast cell degranulating factor 
(Hirai et al.,  1979), mastoparan has been shown to induce 
short-term exocytosis in numerous secretory cell types (Hi- 
rai et al., 1979; Kuroda et al., 1980; Camoratto and Grandi- 
son,  1985; Kurihara et al.,  1986; Yokokawa et al.,  1989). 
To our knowledge, this is the first time that mastoparan has 
been shown to stimulate reinitiation of DNA synthesis in any 
target cell. 
The mechanism(s) of action of  mastoparan is attracting in- 
terest because  this  peptide  may  mimic  the  receptor do- 
main(s) that directly activates G  proteins either in recon- 
stituted phospholipid vesicles or in intact cells (Higashijima 
et al.,  1988,  1990; Mousli et al.,  1990; Weingarten et al., 
1990). It is known that mastoparan regulates the activity of 
purified G proteins (e.g., Go and Gi) over a narrow range of 
concentration  (Higashijima  et  al.,  1990).  In  the  present 
study we showed that mastoparan stimulation of DNA syn- 
thesis in 3T3 cells was steeply dose-dependent. The coopera- 
tivity of these dose responses suggests that several molecules 
of mastoparan bound to phospholipid brayers may be re- 
quired to activate G protein activity either in vitro or in intact 
cells. 
In certain cell types, mastoparan stimulates polyphospho- 
inositide-specific phospholipase C (Okano et al., 1985; Peri- 
anin and Snyderman, 1989; Tohkin et al., 1990), leading to 
Ca  2+ mobilization and activation of protein kinas¢ C, a path- 
way known to be regulated by a G protein and involved in 
mitogenic signaling  by neuropeptides and growth  factors 
(Rozengurt, 1986). The results presented here demonstrate 
that this is not the case in Swiss 3"I"3  cells as judged by mea- 
surements of inositol phosphate accumulation, Ca  2+ mobili- 
zation, and protein kinase C-mediated phosphorylation of 
the 80 K substrate and EGF receptor transmodulation. Fur- 
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mitogenic signaling  via this pathway (Rodriguez-Pena  and 
Rozengurt,  1984; Rozengurt et al., 1984) did not prevent the 
mitogenic response initiated by mastoparan. From these re- 
suits we conclude that mastoparan stimulation  of DNA syn- 
thesis can be dissociated from phospholipase C  activation 
and consequently,  that the peptide stimulates  a different sig- 
naling pathway. 
In the present study we demonstrate that mastoparan in- 
duces a striking  release of arachidonic  acid and  its cyclo- 
oxygenase metabolite PGFa into the medium.  Recent evi- 
dence has indicated  that  the liberation of arachidonic  acid 
and its conversion to eicosanoids constitutes one of the early 
mitogenic signals induced by bombesin in 3"1"3 cells (Millar 
and Rozengurt,  1990). It is also noteworthy that the PDGF 
AA and PDGF BB homodimers that, like bombesin, stimu- 
late reinitiation  of DNA synthesis  in the absence of other 
growth promoting factors induce  a large and sustained  re- 
lease of arachidonic  acid in Swiss 3T3 cells (Mehmet et al., 
1990). The results presented here with mastoparan also sup- 
port the conclusion that arachidonic  acid release contributes 
to mitogenic signal transduction.  However, since the inhibi- 
tion of arachidonic  acid release by pertussis toxin treatment 
was more pronounced than the inhibition  of [3H]thymidine 
incorporation,  we cannot exclude the possibility that mas- 
toparan induces cellular DNA synthesis through  additional 
signaling  pathways. 
Arachidonic  acid may be liberated as a result of either di- 
rect action of PLA2 or by indirect  routes involving the re- 
lease of arachidonic  acid from diacylglycerol by diglyceride 
lipase. Arachidonic  acid-containing diacylglycerol is one of 
the most potent physiological  activators  of protein kinase C 
(Nishizuka,  1986). Here we showed that mastoparan stimu- 
lates arachidonic  acid release without causing concomitant 
inositol phosphate accumulation  or activation of protein ki- 
nase C. In contrast, vasopressin which stimulates phospholi- 
pase C-mediated phosphoinositide breakdown,  diacylgly- 
cerol  formation,  and  activates  protein kinase  C  does not 
cause sustained stimulation of arachidonic  acid release from 
Swiss 3T3 cells (Millar and Rozengurt,  1990). Hence, ara- 
chidonic  acid release can be separated from diacylglycerol 
formation in these cells. We conclude that mastoparan stim- 
ulates arachidonic  acid release from 3T3 cells through  acti- 
vation of PLA2. 
Previous studies demonstrated that mastoparan stimulates 
the activity of purified PLA2 reconstituted into  phospho- 
lipid vesicles, presumably interacting with the phospholipids 
and rendering  them more susceptible to PLA2 action (Ar- 
giolas and Pisano,  1983).  Our results using pertussis toxin 
that catalyses ADP-ribosylation of the c~ subunits of G pro- 
teins (Ui, 1990) suggest that in 3T3 cells mastoparan stimu- 
lates  PLA2 activity via  an  entirely  different  mechanism. 
Treatment with pertussis toxin of 3T3 ceils markedly attenu- 
ated the ability of mastoparan to stimulate arachidonic  acid 
release,  PGE2 production, and enhancement  of cAMP ac- 
cumulation.  These findings indicate that mastoparan stimu- 
lates arachidonic  acid release via a pertussis toxin-sensitive 
G protein, rather than by interaction  with cellular phospho- 
lipids.  In contrast,  pertussis toxin does not interfere  with 
phospholipase C activation by either bombesin (Zachary et 
al., 1987) or vasopressin (Erusalimsky  and Rozengurt, 1989) 
in Swiss 3T3 cells. Recently, the possibility has been raised 
that PLA~ is directly regulated  by a pertussis toxin-sensi- 
tive G protein and that  separate  G proteins transduce re- 
ceptor-mediated activation  of PLA~ and phospholipase C 
(Axelrod,  1990). In this context,  the results presented here 
suggest  that  mastoparan  selectively  stimulates  a  perttissis 
toxin-sensitive  G protein that regulates PLA2 activity in in- 
tact 3T3 cells. In conclusion, mastoparan should be a useful 
probe to  elucidate  G-protein  coupled signal  transduction 
pathways in the mitogenic response. 
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